Technical Analysis for AVXL - Anavex Life Sciences Corp.

Grade Last Price % Change Price Change
grade C 2.71 1.88% 0.05
AVXL closed up 1.88 percent on Wednesday, August 21, 2019, on 26 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical AVXL trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.88%
200 DMA Support Bullish 1.88%
Inside Day Range Contraction 1.88%
Overbought Stochastic Strength 1.88%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.45%
200 DMA Support Bullish -1.45%
Doji - Bearish? Reversal -1.45%

Older signals for AVXL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Anavex Life Sciences Corp., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of Alzheimer's disease, central nervous system diseases, and pain and various cancers. Its lead drug candidates include ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), which is in a Phase IIa clinical trial for the treatment of Alzheimer's disease. The company's product candidates also include ANAVEX 3-71, a drug candidate that is effective in very small doses against the major Alzheimer's hallmarks in transgenic (3xTg-AD) mice via sigma-1 receptor activation and M1 muscarinic allosteric modulation; ANAVEX 1-41, a sigma-1 agonist for neuroprotective application; and ANAVEX 1037, ANAVEX 1079, and ANAVEX 1519 for the treatment of pain and various cancers. Anavex Life Sciences Corp. was founded in 2006 and is headquartered in New York, New York.
Biopharmaceutical Pain Chemical Compounds Cancers Neuroscience Alzheimer's Disease Alzheimer's Treatment Of Alzheimer's Disease Central Nervous System Diseases Piperidines Nootropics
Is AVXL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 15 Edited Transcript of AVXL earnings conference call or presentation 7-Aug-19 8:30pm GMT
Aug 8 Anavex Life Sciences' (AVXL) CEO Christopher Missling on Q3 2019 Results - Earnings Call Transcript
Aug 7 Anavex Life Sciences EPS beats by $0.03
Aug 7 Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates
Aug 6 What's in the Cards for Perrigo (PRGO) This Earnings Season?
Aug 5 Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?
Aug 2 Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?
Aug 2 What's in Store for Cardinal Health (CAH) in Q4 Earnings?
Aug 2 Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019
Aug 1 Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?
See more AVXL news...
Indicators
Indicator Value
52 Week High 4.09
52 Week Low 1.25
Average Volume 549,018
200-Day Moving Average 2.6399
50-Day Moving Average 2.9234
20-Day Moving Average 2.51
10-Day Moving Average 2.556
Average True Range 0.1924
ADX 15.25
+DI 23.2111
-DI 16.0444
Chandelier Exit (Long, 3 ATRs ) 2.2487
Chandelier Exit (Short, 3 ATRs ) 2.7872
Upper Bollinger Band 2.7702
Lower Bollinger Band 2.2498
Percent B (%b) 0.88
BandWidth 20.733068
MACD Line -0.0586
MACD Signal Line -0.1208
MACD Histogram 0.0622
Fundamentals Value
Market Cap 114.29 Million
Num Shares 42.2 Million
EPS -0.38
Price-to-Earnings (P/E) Ratio -7.13
Price-to-Sales 0.00
Price-to-Book 7.34
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.89
Resistance 3 (R3) 2.89 2.83 2.86
Resistance 2 (R2) 2.83 2.78 2.83 2.85
Resistance 1 (R1) 2.77 2.76 2.80 2.77 2.84
Pivot Point 2.71 2.71 2.73 2.71 2.71
Support 1 (S1) 2.65 2.66 2.68 2.65 2.58
Support 2 (S2) 2.59 2.64 2.59 2.57
Support 3 (S3) 2.53 2.59 2.56
Support 4 (S4) 2.53